Andrea Vecchione

Publications

Title Published on Year
KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2 CLINICAL EPIGENETICS 2018
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells ONCOTARGET 2018
Loss of miR-204 expression is a key event in melanoma MOLECULAR CANCER 2018
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients JOURNAL OF NEUROIMMUNOLOGY 2018
Cigarette smoking is not associated with prostate cancer diagnosis and agressiveness: a cross sectional italian study MINERVA UROLOGICA E NEFROLOGICA 2018
Exploring the role of fallopian ciliated cells in the pathogenesis of high-grade serous ovarian cancer INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2018
Cigarette smoking is not associated with prostate cancer diagnosis and aggressiveness. a cross sectional Italian study MINERVA UROLOGICA E NEFROLOGICA 2018
Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia ONCOTARGET 2017
An integrated approach identifies mediators of local recurrence in head and neck squamous carcinoma CLINICAL CANCER RESEARCH 2017
PD61-11 THE NEW EPSTEIN GLEASON SCORE CLASSIFICATION SIGNIFICANTLY REDUCES UPGRADING IN PROSTATE CANCER PATIENTS THE JOURNAL OF UROLOGY 2017
microRNA. Diagnostic Perspective FRONTIERS IN MEDICINE 2015
P27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2015
c-Met and miRs in cancer BIOMEDICINES 2015
Fhit loss in lung preneoplasia: Relation to DNA damage response checkpoint activation CANCER LETTERS 2015

ERC

  • LS1
  • LS1_3
  • LS1_4
  • LS1_9

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Keywords

miRNA
breast cancer
cancer biology

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma